Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely bisoprolol 2.5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 50 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 50 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 25 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Captopril 25 mg and hydrochlorothiazide 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Captopril 25 mg and hydrochlorothiazide 12.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril 10 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril 10 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and losartan potassium 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Captopril 25 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Captopril 25 mg and hydrochlorothiazide 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg and telmisartan 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg and telmisartan 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 25 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and losartan potassium 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and losartan potassium 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
énalapril 10 mg et hydrochlorothiazide 25 mg, comprimé oral |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
énalapril 10 mg et hydrochlorothiazide 25 mg, comprimé oral |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
énalapril 5 mg et hydrochlorothiazide 12,5 mg, comprimé oral |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
énalapril 5 mg et hydrochlorothiazide 12,5 mg, comprimé oral |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril 20 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 50 mg and reserpine 125 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 50 mg and reserpine 125 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fosinopril 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fosinopril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fosinopril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and timolol maleate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and timolol maleate 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely bisoprolol 2.5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
2 |
Hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrochlorothiazide (substance) |
Inferred relationship |
Some |
1 |